{
    "eid": "2-s2.0-85106843244",
    "title": "Meet our editorial board member",
    "cover-date": "2016-12-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "General Neuroscience",
            "@code": "2800"
        }
    ],
    "keywords": [],
    "authors": [
        "Michael Maes"
    ],
    "citedby-count": 0,
    "ref-count": 5,
    "ref-list": [
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications",
        "Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: Inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression",
        "In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes",
        "So depression is an inflammatory disease, but where does the inflammation come from?"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}